Hainan Linyi Biotechnology

Hainan Linyi Biotechnology is an innovative Chinese biotechnology company focused on the development of advanced transdermal drug delivery systems, specifically dissolvable microneedle patches. The company's core technology platform enables the painless delivery of large-molecule biologics, such as insulin, GLP-1 receptor agonists, and vaccines, which traditionally require subcutaneous injection. By utilizing biocompatible and biodegradable materials, their patches aim to improve patient compliance, eliminate needle-stick injuries, and enhance drug stability at room temperature. Hainan Linyi is currently advancing a pipeline of programs targeting chronic metabolic diseases and infectious disease prevention. The company is strategically located in the Hainan Free Trade Port to leverage regional incentives for high-tech medical innovation.